Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sino Biopharmaceutical Unsponsored Caymand Islands ADR SBHMY

Alternate Symbol(s):  SBMFF

Healthcare Biotechnology
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly... see more

Current News (PINL:SBHMY)

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion

ACN Newswire May 24, 2021

Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity

ACN Newswire March 23, 2021

Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China

ACN Newswire December 6, 2020

Sino Biopharmaceutical Announces 2020 Third Quarterly Results

ACN Newswire November 30, 2020

Sino Biopharm Announces 2020 Interim Results

ACN Newswire August 28, 2020

Sino Biopharmaceutical Announces 2020 First Quarterly Results

ACN Newswire May 28, 2020

New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration

ACN Newswire May 26, 2020

Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting

ACN Newswire May 19, 2020

Sino Biopharm Announces 2019 Annual Results

ACN Newswire March 30, 2020
View More News ››

Opinion & Analysis (PINL:SBHMY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:SBHMY)

Be the first to post on this bullboard.

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is an international oil and gas exploration company with a focus on operations and opportunities in the Middle ...
View More »